The move comes in response to increasing delivery demands for GLP-1s, plus broader conversations about pharmaceutical ...
BD (Becton, Dickinson and Company) was founded in 1897 by Maxwell Becton and Fairleigh Dickinson. For over 125 years, BD has ...
Medical Device Network on MSN
BD secures FDA 510(k) clearance for EnCor EnCompass system
"BD secures FDA 510 (k) clearance for EnCor EnCompass system" was originally created and published by Medical Device Network, ...
Becton, Dickinson and Company is a leading medical device firm specializing in medical supplies, devices, laboratory equipment, and diagnostic products. BDX operates in three segments: BD Medical, BD ...
State-of-the-art, multi-modality breast biopsy system slated to be in the market in early 2026 FRANKLIN LAKES, N.J., Jan. 15, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: ...
2d
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Becton Dickinson (BDX) and Moderna (MRNA)
Detailed price information for Becton Dickinson and Company (BDX-N) from The Globe and Mail including charting and trades.
Oakmark Funds, advised by Harris Associates, released its “Oakmark Global Fund” second quarter 2025 investor letter. The fund underperformed its benchmark, the MSCI World Index (net), in the second ...
Becton, Dickinson and Company is ready to unveil its fiscal first-quarter earnings soon, and analysts project a double-digit ...
Becton, Dickinson and Company reported strong Q4 2025 results, with revenue up 8.3% and adjusted EPS up 3.9% year-over-year. Despite healthy growth, BDX's organic growth remains modest, and management ...
Oakmark Funds, advised by Harris Associates, released its “Oakmark Global Fund” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. The fund returned -5.78% in the ...
With a market cap of $64 billion, Franklin Lakes, New Jersey-based Becton, Dickinson and Company (BDX) is a global medical technology leader. Operating through three key segments: BD Medical; BD Life ...
Testing companies have revealed little about how their products perform in minors. That could be a problem. By Katherine J. Wu The reversal came just hours after the federal government threatened the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback